Eventide Asset Management - Q3 2016 holdings

$1.64 Billion is the total value of Eventide Asset Management's 125 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 20.2% .

 Value Shares↓ Weighting
MIC BuyMACQUARIE INFRASTRUCTURE COR$59,658,000
+12.9%
716,700
+0.4%
3.64%
+12.6%
FPRX SellFIVE PRIME THERAPEUTICS INC$53,288,000
+18.8%
1,015,200
-6.5%
3.25%
+18.5%
LEA  LEAR CORP$53,216,000
+19.1%
439,0000.0%3.25%
+18.8%
ABBV BuyABBVIE INC$52,676,000
+2.6%
835,200
+0.7%
3.22%
+2.3%
XPO SellXPO LOGISTICS INC$52,071,000
+22.5%
1,420,000
-12.3%
3.18%
+22.2%
CELG SellCELGENE CORP$49,683,000
-28.3%
475,300
-32.3%
3.03%
-28.5%
LRCX SellLAM RESEARCH CORP$46,607,000
-17.0%
492,100
-26.3%
2.84%
-17.2%
SGEN  SEATTLE GENETICS INC$45,126,000
+33.7%
835,5060.0%2.76%
+33.3%
LOW SellLOWES COS INC$44,770,000
-15.0%
620,000
-6.8%
2.73%
-15.2%
KAR SellKAR AUCTION SVCS INC$38,844,000
+2.8%
900,000
-0.6%
2.37%
+2.6%
COLL BuyCOLLEGIUM PHARMACEUTICAL INC$38,718,000
+67.5%
2,010,278
+3.1%
2.36%
+67.2%
MBBYF  MOBILEYE N V AMSTELVEEN$37,198,000
-7.7%
873,8000.0%2.27%
-7.9%
BLUE  BLUEBIRD BIO INC$36,567,000
+56.6%
539,5000.0%2.23%
+56.2%
IPHI  INPHI CORP$34,769,000
+35.8%
799,1000.0%2.12%
+35.6%
PANW SellPALO ALTO NETWORKS INC$32,663,000
+18.4%
205,000
-8.9%
1.99%
+18.1%
MGA BuyMAGNA INTL INC$32,118,000
+24.2%
747,800
+1.4%
1.96%
+23.9%
STLD SellSTEEL DYNAMICS INC$31,862,000
-12.7%
1,275,000
-14.5%
1.94%
-13.0%
SPLK SellSPLUNK INC$29,340,000
-17.7%
500,000
-24.0%
1.79%
-17.9%
WBC  WABCO HLDGS INC$29,018,000
+24.0%
255,6000.0%1.77%
+23.7%
CCI SellCROWN CASTLE INTL CORP NEW$28,814,000
-46.0%
305,850
-41.8%
1.76%
-46.1%
PFPT SellPROOFPOINT INC$28,817,000
-7.3%
385,000
-21.9%
1.76%
-7.6%
WAB  WABTEC CORP$28,578,000
+16.3%
350,0000.0%1.74%
+16.0%
CYBR SellCYBERARK SOFTWARE LTD$27,264,000
-19.8%
550,000
-21.4%
1.66%
-20.0%
STKL  SUNOPTA INC$27,058,000
+68.5%
3,832,6000.0%1.65%
+68.1%
CRUS  CIRRUS LOGIC INC$26,575,000
+37.0%
500,0000.0%1.62%
+36.6%
ATHN  ATHENAHEALTH INC$25,375,000
-8.6%
201,2000.0%1.55%
-8.8%
IDTI  INTEGRATED DEVICE TECHNOLOGY$24,179,000
+14.8%
1,046,7000.0%1.48%
+14.5%
ASML SellASML Holding NV$21,916,000
-29.4%
200,000
-36.0%
1.34%
-29.5%
MGNX  MACROGENICS INC$21,709,000
+10.8%
725,8000.0%1.32%
+10.5%
AYI NewACUITY BRANDS INC$21,168,00080,000
+100.0%
1.29%
CAFD Buy8POINT3 ENERGY PARTNERS LPcl a rpt ltdpt$21,060,000
+16.3%
1,462,500
+27.6%
1.29%
+16.0%
PEGI BuyPATTERN ENERGY GROUP INCcl a$19,791,000
+0.1%
880,000
+2.3%
1.21%
-0.2%
LOXO  LOXO ONCOLOGY INC$19,373,000
+12.9%
740,0000.0%1.18%
+12.7%
NEP BuyNEXTERA ENERGY PARTNERS LP$19,243,000
-4.4%
688,000
+3.8%
1.18%
-4.6%
ARW  ARROW ELECTRS INC$18,871,000
+3.3%
295,0000.0%1.15%
+3.1%
AY SellATLANTICA YIELD PLC$17,366,000
+2.2%
913,500
-0.1%
1.06%
+1.9%
VCYT  VERACYTE INC$17,138,000
+51.3%
2,252,0000.0%1.05%
+50.9%
AGIO  AGIOS PHARMACEUTICALS INC$15,888,000
+26.1%
300,8000.0%0.97%
+25.8%
XLRN  ACCELERON PHARMA INC$15,522,000
+6.5%
428,9000.0%0.95%
+6.3%
BWA  BORGWARNER INC$15,479,000
+19.2%
440,0000.0%0.94%
+18.9%
ROL NewROLLINS INC$14,347,000490,000
+100.0%
0.88%
SNA NewSNAP ON INC$13,676,00090,000
+100.0%
0.84%
ORA SellORMAT TECHNOLOGIES INC$13,408,000
+9.1%
276,959
-1.4%
0.82%
+8.9%
WSO NewWATSCO INC$12,681,00090,000
+100.0%
0.77%
DOOR NewMASONITE INTL CORP NEW$12,602,000202,700
+100.0%
0.77%
HASI BuyHANNON ARMSTRONG SUST INFR C$12,448,000
+13.5%
532,667
+4.9%
0.76%
+13.3%
WVE  WAVE LIFE SCIENCES LTD$12,339,000
+56.9%
380,0000.0%0.75%
+56.5%
SUPN SellSUPERNUS PHARMACEUTICALS INC$11,005,000
-6.0%
445,000
-22.6%
0.67%
-6.3%
ACAD  ACADIA PHARMACEUTICALS INC$10,647,000
-2.0%
334,7000.0%0.65%
-2.3%
STML  STEMLINE THERAPEUTICS INC$9,221,000
+60.0%
851,4000.0%0.56%
+59.5%
DBVT  DBV TECHNOLOGIES S Asponsored adr$9,068,000
+11.4%
249,6000.0%0.55%
+11.2%
ONCE  SPARK THERAPEUTICS INC$9,009,000
+17.5%
150,0000.0%0.55%
+17.3%
AYR  AIRCASTLE LTD$8,512,000
+1.5%
428,6000.0%0.52%
+1.4%
GWPH SellGW PHARMACEUTICALS PLCads$8,428,000
+25.2%
63,500
-13.6%
0.52%
+25.0%
XNCR  XENCOR INC$8,425,000
+29.0%
344,0000.0%0.51%
+28.5%
KITE  KITE PHARMA INC$8,301,000
+11.7%
148,6000.0%0.51%
+11.4%
TSLA  TESLA MTRS INC$8,161,000
-3.9%
40,0000.0%0.50%
-4.2%
BPMC  BLUEPRINT MEDICINES CORP$7,871,000
+46.7%
265,0000.0%0.48%
+46.6%
SAGE  SAGE THERAPEUTICS INC$7,829,000
+52.9%
170,0000.0%0.48%
+52.7%
TSRO SellTESARO INC$7,518,000
-0.6%
75,000
-16.7%
0.46%
-0.9%
PRTA  Prothena Corp PLC$7,196,000
+71.5%
120,0000.0%0.44%
+70.8%
CSLT  CASTLIGHT HEALTH INCcl b$7,108,000
+5.1%
1,708,6000.0%0.43%
+4.8%
BMRN  BIOMARIN PHARMACEUTICAL INC$6,939,000
+18.9%
75,0000.0%0.42%
+18.8%
 ESSA PHARMA INC$6,828,000
-7.4%
2,719,4100.0%0.42%
-7.5%
CERN  CERNER CORP$6,681,000
+5.4%
108,2000.0%0.41%
+5.2%
EXR SellEXTRA SPACE STORAGE INC$6,353,000
-59.6%
80,000
-52.9%
0.39%
-59.7%
CPN SellCALPINE CORP$6,320,000
-72.0%
500,000
-67.3%
0.39%
-72.0%
NBIX  NEUROCRINE BIOSCIENCES INC$6,330,000
+11.4%
125,0000.0%0.39%
+10.9%
RARE  ULTRAGENYX PHARMACEUTICAL IN$6,200,000
+45.0%
87,4000.0%0.38%
+44.7%
ALNY  ALNYLAM PHARMACEUTICALS INC$6,100,000
+22.1%
90,0000.0%0.37%
+21.6%
NVAX  NOVAVAX INC$4,534,000
-71.4%
2,179,7000.0%0.28%
-71.4%
CEMP  CEMPRA INC$4,475,000
+46.8%
184,9000.0%0.27%
+46.0%
TGTX  TG THERAPEUTICS INC$4,161,000
+27.7%
537,6000.0%0.25%
+27.6%
BOLD NewAUDENTES THERAPEUTICS INC$4,007,000225,000
+100.0%
0.24%
CHRS  COHERUS BIOSCIENCES INC$3,883,000
+58.6%
145,0000.0%0.24%
+58.0%
GBT  GLOBAL BLOOD THERAPEUTICS IN$3,803,000
+38.9%
165,0000.0%0.23%
+38.9%
INCY  INCYTE CORP$3,772,000
+17.9%
40,0000.0%0.23%
+17.3%
VYGR  VOYAGER THERAPEUTICS INC$3,603,000
+9.3%
300,0000.0%0.22%
+8.9%
ACRS NewACLARIS THERAPEUTICS INC$3,585,000140,000
+100.0%
0.22%
TCON  TRACON PHARMACEUTICALS INC$3,500,000
+54.3%
517,7000.0%0.21%
+54.0%
PTI BuyPROTEOSTASIS THERAPEUTICS IN$3,430,000
+41.4%
220,000
+10.0%
0.21%
+41.2%
GLPG  GALAPAGOS NVspon adr$3,362,000
+16.6%
52,0000.0%0.20%
+16.5%
RGEN  REPLIGEN CORP$3,321,000
+10.3%
110,0000.0%0.20%
+10.3%
CDTX  CIDARA THERAPEUTICS INC$3,023,000
+11.1%
264,0000.0%0.18%
+10.8%
VRTX  VERTEX PHARMACEUTICALS INC$3,017,000
+1.4%
34,6000.0%0.18%
+1.1%
NTUS  NATUS MEDICAL INC DEL$2,947,000
+4.0%
75,0000.0%0.18%
+4.0%
ATRC  ATRICURE INC$2,848,000
+12.0%
180,0000.0%0.17%
+11.5%
AGTC  APPLIED GENETIC TECHNOL CORP$2,730,000
-30.8%
279,1000.0%0.17%
-30.7%
JUNO  JUNO THERAPEUTICS INC$2,701,000
-21.9%
90,0000.0%0.16%
-22.2%
EPZM  EPIZYME INC$2,706,000
-3.9%
275,0000.0%0.16%
-4.1%
DVAX  DYNAVAX TECHNOLOGIES CORP$2,623,000
-28.0%
250,0000.0%0.16%
-28.3%
CTMX  CYTOMX THERAPEUTICS INC$2,352,000
+53.5%
150,0000.0%0.14%
+53.2%
TTPH  TETRAPHASE PHARMACEUTICALS I$2,298,000
-10.9%
600,0000.0%0.14%
-11.4%
DRNA  DICERNA PHARMACEUTICALS INC$2,217,000
+96.0%
377,0000.0%0.14%
+95.7%
MCRB  SERES THERAPEUTICS INC$2,190,000
-57.7%
178,2000.0%0.13%
-57.7%
OMED  ONCOMED PHARMACEUTICALS INC$2,172,000
-7.1%
190,0000.0%0.13%
-7.0%
TNDM  TANDEM DIABETES CARE INC$2,107,000
+1.6%
275,0000.0%0.13%
+1.6%
SYRS  SYROS PHARMACEUTICALS INC$2,081,000
-23.6%
150,0000.0%0.13%
-24.0%
ARAY  ACCURAY INC$1,950,000
+22.7%
306,2000.0%0.12%
+22.7%
SEP BuySPECTRA ENERGY PARTNERS LP$1,398,000
+72.4%
32,000
+86.0%
0.08%
+70.0%
IMDZ  IMMUNE DESIGN CORP$1,364,000
-7.1%
180,0000.0%0.08%
-7.8%
JCI NewJOHNSON CTLS INTL PLC$1,210,00026,000
+100.0%
0.07%
BEP BuyBROOKFIELD RENEWABLE PARTNERpartnership unit$1,077,000
+80.7%
35,000
+75.0%
0.07%
+83.3%
HTGC BuyHERCULES CAPITAL INC$1,071,000
+34.7%
79,000
+23.4%
0.06%
+32.7%
ODFL NewOLD DOMINION FGHT LINES INC$1,029,00015,000
+100.0%
0.06%
CPPL BuyCOLUMBIA PIPELINE PARTNERS L$1,017,000
+90.8%
63,000
+77.5%
0.06%
+87.9%
NYLD BuyNRG YIELD INCcl c$1,018,000
+98.1%
60,000
+81.8%
0.06%
+100.0%
TSM BuyTAIWAN SEMICONDUCTOR MFG LTDsponsored adr$948,000
+40.0%
31,000
+20.2%
0.06%
+41.5%
BDN BuyBRANDYWINE RLTY TRsh ben int new$914,000
+57.6%
58,500
+69.6%
0.06%
+60.0%
HMC NewHONDA MOTOR LTD$911,00031,500
+100.0%
0.06%
ZSAN  ZOSANO PHARMA CORP$675,000
-42.5%
888,3000.0%0.04%
-43.1%
ABB BuyABB LTDsponsored adr$597,000
+94.5%
26,500
+71.0%
0.04%
+89.5%
BG BuyBUNGE LIMITED$503,000
+150.2%
8,500
+150.0%
0.03%
+158.3%
ETN BuyEATON CORP PLC$427,000
+23.4%
6,500
+12.1%
0.03%
+23.8%
LPT BuyLIBERTY PPTY TRsh ben int$412,000
+42.1%
10,200
+39.7%
0.02%
+38.9%
APU BuyAMERIGAS PARTNERS L Punit l p int$365,000
+73.8%
8,000
+77.8%
0.02%
+69.2%
LXP BuyLEXINGTON REALTY TRUST$340,000
+131.3%
33,000
+127.6%
0.02%
+133.3%
WBK BuyWESTPAC BKG CORPsponsored adr$350,000
+189.3%
15,400
+180.0%
0.02%
+200.0%
FHB NewFIRST HAWAIIAN INC$336,00012,500
+100.0%
0.02%
ERIC BuyERICSSONadr b sek 10$332,000
+20.3%
46,000
+27.8%
0.02%
+17.6%
BBN  BLACKROCK TAX MUNICPAL BD TR$322,000
-1.8%
13,4500.0%0.02%0.0%
NSC  NORFOLK SOUTHERN CORP$291,000
+14.1%
3,0000.0%0.02%
+12.5%
WELL  WELLTOWER INC$269,000
-1.8%
3,6000.0%0.02%
-5.9%
GLBL BuyTERRAFORM GLOBAL INCcl a$247,000
+782.1%
60,000
+589.7%
0.02%
+650.0%
TERP BuyTERRAFORM PWR INC$216,000
+323.5%
15,500
+233.3%
0.01%
+333.3%
RMR ExitRMR GROUP INCcl a$0-37
-100.0%
0.00%
ExitTESLA MTRS INCnote 0.250% 3/0$0-100,000
-100.0%
-0.01%
NATI ExitNATIONAL INSTRS CORP$0-2,800
-100.0%
-0.01%
VTR ExitVENTAS INC$0-1,700
-100.0%
-0.01%
BAB ExitPOWERSHARES ETF TR IIbuild amer etf$0-4,211
-100.0%
-0.01%
JCI ExitJOHNSON CTLS INC$0-15,200
-100.0%
-0.04%
UFS ExitDOMTAR CORP$0-200,000
-100.0%
-0.43%
MDVN ExitMEDIVATION INC$0-150,000
-100.0%
-0.55%
CSIQ ExitCANADIAN SOLAR INC$0-600,000
-100.0%
-0.56%
DATA ExitTABLEAU SOFTWARE INCcl a$0-270,000
-100.0%
-0.81%
LLTC ExitLINEAR TECHNOLOGY CORP$0-292,600
-100.0%
-0.83%
SPWR ExitSUNPOWER CORP$0-1,000,000
-100.0%
-0.95%
CBI ExitCHICAGO BRIDGE & IRON CO N V$0-488,400
-100.0%
-1.04%
SYNA ExitSYNAPTICS INC$0-390,500
-100.0%
-1.28%
FSLR ExitFIRST SOLAR INC$0-565,000
-100.0%
-1.68%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-11-14
Signatures

The EDGAR filing(s) were signed by:

About Eventide Asset Management

Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.

The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.

The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.

Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.

Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LOWES COS INC40Q3 20233.2%
PALO ALTO NETWORKS INC40Q3 20233.6%
ASML HOLDINGS NV40Q3 20231.9%
NEUROCRINE BIOSCIENCES INC40Q3 20231.1%
REPLIGEN CORP40Q3 20230.5%
VERACYTE INC38Q3 20231.5%
LAM RESEARCH CORP35Q3 20233.4%
XPO LOGISTICS INC34Q1 20233.8%
COLLEGIUM PHARMACEUTICAL INC34Q3 20232.6%
MAGNA INTL INC33Q4 20212.5%

View Eventide Asset Management's complete holdings history.

Latest significant ownerships (13-D/G)
Eventide Asset Management Q3 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cogent Biosciences, Inc.February 14, 20232,589,7783.7%
ESSA Pharma Inc.Sold outFebruary 14, 202300.0%
Freeline Therapeutics Holdings plcFebruary 14, 20235,920,7659.1%
KnowBe4, Inc.Sold outFebruary 14, 202300.0%
Praxis Precision Medicines, Inc.February 14, 20233,518,0627.5%
Prometheus Biosciences, Inc.February 14, 20231,032,9382.2%
SUTRO BIOPHARMA, INC.Sold outFebruary 14, 202300.0%
Vital Farms, Inc.Sold outFebruary 14, 202300.0%
Zymeworks Inc.Sold outFebruary 14, 202300.0%
Entasis Therapeutics Holdings Inc.February 14, 2022590,6021.2%

View Eventide Asset Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Eventide Asset Management's complete filings history.

Compare quarters

Export Eventide Asset Management's holdings